Authors: Brodowicz, T Kostler, WJ Moslinger, R Tomek, S Vaclavik, I Herscovici, V Wiltschke, C Steger, GG Wein, W Seifert, M Kubista, E Zielinski, CC

Citation: T. Brodowicz et al., Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer, BREAST, 9(6), 2000, pp. 338-342

Authors: Brodowicz, T Wolfram, RM Kostler, WJ Tomek, S Vaclavik, I Steger, GG Teleky, B Fugger, R Jakesz, R Zielinski, CC

Citation: T. Brodowicz et al., Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer, ANTI-CANC D, 11(8), 2000, pp. 623-628

Authors: Brodowicz, T Koestler, WJ Tomek, S Vaclavik, I Herscovici, V Wiltschke, C Steger, GG Zielinski, CC

Citation: T. Brodowicz et al., Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer, ANTI-CANC D, 11(3), 2000, pp. 149-153

Authors: Auerbach, L Rosen, AC Hafner, E Vaclavik, I Obwegeser, R Asseryanis, E Rosen, HR Moroz, C

Citation: L. Auerbach et al., Placental isoferritin (PLF): Early predictor of fetal growth retardation, GYNAKOL GEB, 39(4), 1999, pp. 195-198